COM:UROGEN
UroGen Pharma
- Stock
Last Close
11.55
22/11 21:00
Market Cap
502.60M
Beta: -
Volume Today
390.58K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.69M - | -1.94M 84.70% | -20M 930.40% | -75.66M 278.28% | -105.15M 38.98% | -128.48M 22.20% | -110.82M 13.75% | -109.78M 0.94% | -102.24M 6.87% | |
depreciation and amortization | 113K - | 213K 88.50% | 207K 2.82% | 417K 101.45% | 1.32M 217.51% | 2.04M 54.38% | 1.77M 13.26% | 1.82M 2.48% | 1.71M 6.16% | |
deferred income tax | 240K - | -572K - | 439K 176.75% | 15.32M 3,390.66% | -68K - | |||||
stock based compensation | 449K - | 1.97M 338.08% | 6.30M 220.28% | 30.64M 386.38% | 29.97M 2.20% | 28.02M 6.48% | 23.11M 17.53% | 10.58M 54.22% | 9.34M 11.69% | |
change in working capital | 609K - | 1.21M 98.69% | 3.76M 210.50% | 7.16M 90.68% | 4.32M 39.70% | -6.37M 247.43% | -13.11M 105.78% | -6.31M 51.88% | 3.34M 152.90% | |
accounts receivables | -83K - | 83K 200% | 3.29M 3,867.47% | -7.05M - | -4.67M 33.72% | -987K 78.87% | -2.74M 177.51% | |||
inventory | -105K - | -211K 100.95% | 316K 249.76% | -1.96M - | -2.87M 46.03% | -362K 87.38% | -1.35M 272.38% | |||
accounts payables | 1.16M - | 481K 58.35% | 2.53M 426.82% | 4.21M 65.94% | 2.93M 30.37% | -1.25M 142.52% | 2.00M 260.48% | 281K 85.94% | 4.16M 1,378.65% | |
other working capital | -546K - | 917K 267.95% | 1.35M 47.33% | -650K 148.11% | 1.39M 314.15% | 3.89M 179.24% | -7.57M 294.62% | -5.24M 30.76% | 3.27M 162.39% | |
other non cash items | 4.10M - | 2.74M 33.22% | 165K 93.98% | 100K 39.39% | -910K 1,010% | -1.54M 69.34% | -1.18M 23.69% | 16.13M 1,471.85% | 11.55M 28.40% | |
net cash provided by operating activities | -7.17M - | 4.19M 158.38% | -9.57M 328.48% | -37.33M 290.07% | -71.02M 90.22% | -105.89M 49.10% | -84.89M 19.83% | -87.56M 3.14% | -76.38M 12.77% | |
investments in property plant and equipment | -301K - | -695K 130.90% | -271K 61.01% | -560K 106.64% | -325K 41.96% | -1.22M 273.85% | -752K 38.11% | -254K 66.22% | -194K 23.62% | |
acquisitions net | -94.45M - | -4.82M 94.90% | -1.31M 72.74% | |||||||
purchases of investments | -36.00M - | -197.69M - | -29.69M 84.98% | -51.90M 74.81% | -63.01M 21.41% | -49.83M 20.91% | ||||
sales maturities of investments | 35.90M - | 52.59M 46.49% | 124.14M 136.05% | 56.72M 54.31% | 64.32M 13.41% | 49.07M 23.71% | ||||
other investing activites | -98K - | -105K 7.14% | -54K 48.57% | -172K 218.52% | 94.45M 55,014.53% | 4.82M 94.90% | 1.31M 72.74% | |||
net cash used for investing activites | -301K - | -793K 163.46% | -36.38M 4,487.26% | 35.29M 197.00% | -145.59M 512.60% | 93.24M 164.04% | 4.07M 95.64% | 1.06M 73.95% | -953K 189.91% | |
debt repayment | -95.78M - | |||||||||
common stock issued | 60.84M - | 64.23M 5.58% | 161.66M 151.67% | 15.85M 90.19% | -83K 100.52% | 1.35M 1,727.71% | 116.93M 8,555.14% | |||
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | 21.58M - | -9K 100.04% | 744K 8,366.67% | 2.19M 193.82% | 3.59M 64.14% | 674K 81.22% | 72.40M 10,642.14% | 191.57M 164.59% | ||
net cash used provided by financing activities | 21.58M - | -9K 100.04% | 61.59M 684,377.78% | 66.42M 7.85% | 165.25M 148.79% | 16.53M 90.00% | 72.32M 337.58% | 97.13M 34.31% | 116.93M 20.38% | |
effect of forex changes on cash | ||||||||||
net change in cash | 14.11M - | 3.39M 75.99% | 15.64M 361.68% | 64.37M 311.68% | -51.36M 179.78% | 3.88M 107.55% | -8.50M 319.23% | 10.63M 225.06% | 39.60M 272.37% | |
cash at beginning of period | 3.87M - | 17.98M 364.47% | 21.36M 18.84% | 37.20M 74.13% | 101.57M 173.06% | 50.21M 50.57% | 54.09M 7.73% | 45.59M 15.72% | 56.22M 23.33% | |
cash at end of period | 17.98M - | 21.36M 18.84% | 37.00M 73.20% | 101.57M 174.52% | 50.21M 50.57% | 54.09M 7.73% | 45.59M 15.72% | 56.22M 23.33% | 95.82M 70.44% | |
operating cash flow | -7.17M - | 4.19M 158.38% | -9.57M 328.48% | -37.33M 290.07% | -71.02M 90.22% | -105.89M 49.10% | -84.89M 19.83% | -87.56M 3.14% | -76.38M 12.77% | |
capital expenditure | -301K - | -695K 130.90% | -271K 61.01% | -560K 106.64% | -325K 41.96% | -1.22M 273.85% | -752K 38.11% | -254K 66.22% | -194K 23.62% | |
free cash flow | -7.48M - | 3.49M 146.74% | -9.84M 381.68% | -37.89M 285.02% | -71.34M 88.27% | -107.10M 50.12% | -85.64M 20.03% | -87.81M 2.53% | -76.57M 12.80% |
All numbers in (except ratios and percentages)